DEFRATAJ Immediate Shipment Capability

Safety-stock backed immediate shipment of DEFRATAJ - samples 3-5 days, bridging supply 7-14 days, full PO 30-60 days with weekly production visibility.


Taj Pharma maintains safety-stock allocations of DEFRATAJ Deferasirox to enable rapid dispatch for sample, bridging and urgent supply requirements - while full purchase orders are released against agreed production lead times with weekly status visibility.

Stock Strategy #

  • Safety-stock blocks of the most-requested strengths (250 mg, 400 mg, 500 mg) held at our finished-goods warehouse in standard blister packaging
  • Stock typically sufficient for sample dispatch and bridging supply while larger orders are in production
  • Customer-dedicated stock holding arranged for strategic partners against annual commitment

Dispatch Timelines (from order confirmation) #

Shipment TypeTypical Timeline
Samples (standard blister)3-5 business days by courier
Stock-dispatch bridging supply7-14 business days (dependent on customs / freight booking)
Full production PO (standard packaging)30-60 days from PO to dispatch-ready
Full production PO (custom artwork / tender)60-90 days including artwork approval cycle

Emergency Supply #

For urgent clinical or tender needs (e.g. patient continuity of supply after a registration delay with another supplier), we coordinate expedited documentation, air-freight and dedicated QA batch release. Emergency requests can be submitted through the Bulk Inquiry flagged as urgent.

Production Visibility #

  • Weekly production status reports for open orders
  • Named export coordinator per major order
  • Pre-dispatch inspection photos on request
  • Live milestone tracking (dispensing / granulation / compression / packaging / QC / release / dispatch)

Reliability Commitment #

Where delays are foreseeable (e.g. input-material supply issue, long-weekend port closures), we proactively inform the customer with a revised timeline and mitigation plan - including partial dispatch where appropriate. Our goal is no-surprise delivery, supported by transparent weekly reporting.